Holen Sie sich die Stockscreener-App
105.05
2.93%
2.99
Handel nachbörslich:
105.05
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RVTY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$102.06
Offen:
$101.3
24-Stunden-Volumen:
1.48M
Relative Volume:
1.07
Marktkapitalisierung:
$11.91B
Einnahmen:
$2.77B
Nettoeinkommen (Verlust:
$286.61M
KGV:
44.70
EPS:
2.35
Netto-Cashflow:
$524.11M
1W Leistung:
+7.82%
1M Leistung:
+4.23%
6M Leistung:
+3.69%
1J Leistung:
-9.12%
1-Tages-Spanne:
$101.30
$106.39
1-Wochen-Bereich:
$96.57
$106.39
52-Wochen-Spanne:
$81.36
$128.28
Revvity Inc Stock (RVTY) Company Profile
Firmenname
Revvity Inc
Sektor
Branche
Telefon
781-663-6900
Adresse
77 4TH AVENUE, WALTHAM
Vergleichen Sie RVTY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
105.05 | 11.57B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
620.72 | 229.63B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
236.59 | 166.25B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
706.83 | 54.48B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.60 | 40.52B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
240.53 | 39.95B | 15.90B | 1.28B | 2.21B | 7.2842 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-12-09 | Eingeleitet | Goldman | Neutral |
| 2025-10-16 | Eingeleitet | Guggenheim | Neutral |
| 2025-05-01 | Hochstufung | UBS | Neutral → Buy |
| 2025-01-10 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-08 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-01-16 | Herabstufung | UBS | Buy → Neutral |
| 2024-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-05-23 | Fortgesetzt | Goldman | Buy |
Alle ansehen
Revvity Inc Aktie (RVTY) Neueste Nachrichten
What to expect from Revvity’s Q4 2025 earnings report - MSN
What to Expect From Revvity’s Q4 2025 Earnings Report - inkl
Do Options Traders Know Something About Revvity (RVTY) Stock We Don't? - MSN
Trading Systems Reacting to (RVTY) Volatility - Stock Traders Daily
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Allspring Global Investments Holdings LLC Has $70.79 Million Stock Holdings in Revvity Inc. $RVTY - MarketBeat
Here’s Why Diamond Hill Mid Cap Composite Purchased Revvity (RVTY) in Q3 - Insider Monkey
Revvity Inc. (NYSE:RVTY) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Revvity Inc.: Quiet Re?Rating Story in a Volatile Diagnostics Market - AD HOC NEWS
Revvity, Inc. Faces Valuation Shift Amid Declining Sales and Rising Costs - Markets Mojo
Revvity Earnings Notes - Trefis
Can Revvity Inc. stock deliver strong annual returnsCandlestick Trading Patterns & Affordable Trading Growth - bollywoodhelpline.com
Revvity Inc. Stock Finds Its Footing as Investors Weigh Diagnostics Demand and AI Ambitions - AD HOC NEWS
Revvity Inc. Stock Price Live, Charts & News - The Economic Times
Revvity, Inc.'s (NYSE:RVTY) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - 富途牛牛
Revvity advances AI-driven scientific discovery with Signals Xynthetica - MSN
Q3 Earnings Highlights: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
(RVTY) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Did Revvity’s New AI Discovery Platform (RVTY) Quietly Redefine Its Innovation Moat? - simplywall.st
Revvity introduces AI-augmented design platform for molecular and materials discovery - BioSpectrum India
Aug Patterns: How Revvity Inc stock reacts to global recession fearsJuly 2025 Summary & Safe Capital Growth Trade Ideas - moha.gov.vn
Is Revvity Inc. stock a defensive play in 2025Global Markets & Stepwise Trade Signal Implementation - Улправда
How cyclical is Revvity Inc. stock compared to rivalsJuly 2025 Price Swings & Comprehensive Market Scan Reports - DonanımHaber
Revvity Advances AI-Driven Scientific Discovery With Signals Xynthetica - TradingView — Track All Markets
Will Revvity Inc. stock reach all time highs in 2025Weekly Trade Report & Expert Verified Stock Movement Alerts - DonanımHaber
Raymond James reiterates Outperform rating on Revvity stock after site visit - Investing.com Nigeria
Raymond James reiterates Outperform rating on Revvity stock after site visit By Investing.com - Investing.com India
What consensus target says about Revvity Inc. stockRate Cut & AI Optimized Trade Strategies - DonanımHaber
Why Revvity Inc. stock could outperform in 2025Weekly Profit Analysis & Precise Buy Zone Tips - DonanımHaber
Will Revvity Inc. stock benefit from automationJuly 2025 Closing Moves & Technical Buy Zone Confirmations - Улправда
Is Revvity Inc. stock a buy on dipsWeekly Trading Summary & Daily Price Action Insights - Улправда
What analyst consensus says on Revvity Inc. stockInsider Selling & Proven Capital Preservation Tips - Улправда
Revvity (BSP:R1VT34) EV-to-OCF : 22.14 (As of Dec. 18, 2025) - GuruFocus
Will Revvity Inc. stock see PE expansionMarket Activity Summary & High Conviction Buy Zone Picks - ulpravda.ru
Revvity to Present at J.P. Morgan Healthcare Conference - Business Wire
Does Revvity (NYSE:RVTY) Have A Healthy Balance Sheet? - simplywall.st
How is Revvity's stock performance compared to other health care stocks? - MSN
Revvity (NYSE: RVTY) officer disposes 25 shares for RSU tax withholding - Stock Titan
3 Reasons RVTY is Risky and 1 Stock to Buy Instead - The Globe and Mail
Revvity unveils AI-powered Signals Xynthetica to accelerate molecular and materials design - Indian Pharma Post
Revvity Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Revvity to launch AI models-as-a-service for scientific discovery - Investing.com Nigeria
Revvity Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials D - PharmiWeb.com
Revvity Introduces New AI Service for Molecular, Materials Design - marketscreener.com
Revvity, Inc. Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials Discovery - marketscreener.com
Barclays Maintains Revvity (RVTY) Overweight Recommendation - Nasdaq
Revvity Inc. stock underperforms Monday when compared to competitors - MarketWatch
Revvity Shares Fall After BofA Downgrade - marketscreener.com
Revvity stock rating downgraded to Neutral by BofA Securities - Investing.com South Africa
Finanzdaten der Revvity Inc-Aktie (RVTY)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.85%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):